Clinical Trials Browser

Enrolling by invitation × Interventional × Thoracic × Clear all

NCT07218003 2026-03-23

A Phase 1/1b of RNDO-564 Single Agent or in Combination With Pembrolizumab in Bladder Cancer and Other Solid Tumors Associated With Nectin-4

Phase 1 Enrolling by invitation

BreastGastrointestinalGenitourinaryGynecologicThoracic

Esophageal Squamous Cell Carcinoma, Adenocarcinoma, Urinary Bladder Neoplasms, Carcinoma, Non-Small-Cell Lung, Uterine Cervical Neoplasms, Neoplasms, Stomach Neoplasms, Triple Negative Breast Neoplasms

NCT07401498 2026-02-10

LNDNSCLC-RUS

Phase NA Enrolling by invitation

Lymph Node Dissection

NCT06250777 2026-02-09

ELPIS

Phase 2 Enrolling by invitation

Carcinoma, Non-Small-Cell Lung

NCT07390565 2026-02-09

YSQTG Combined With Immuno-chemotherapy for Extensive-Stage Small Cell Lung Cancer

Phase NA Enrolling by invitation

Small Cell Lung Carcinoma

NCT06370416 2026-01-28

the Prevention of Bone Marrow Suppression Caused by Chemotherapy in Advanced NSCLC With Trilaciclib

Phase 2 Enrolling by invitation

Carcinoma, Non-Small-Cell Lung

NCT04945317 2025-12-17

ROSE/NoROSE

Phase NA Enrolling by invitation

Carcinoma, Non-Small-Cell Lung

NCT06281964 2025-12-16

KANNON-2

Phase 3 Enrolling by invitation

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT07285434 2025-12-16

Microlyvaq™

Phase EARLY_PHASE1 Enrolling by invitation

Carcinoma, Non-Small-Cell Lung

NCT07216144 2025-12-10

CLEAR

Phase NA Enrolling by invitation

Lung Cancer Screening

NCT06324110 2025-11-20

Evaluating the Impact of Centralized Interventions on Lung Cancer Screening Adherence in Community Settings, ACCELL Trial

Phase NA Enrolling by invitation

Lung Neoplasms

NCT06603987 2025-11-19

Using CICS-1 and SPM-011 and ［18F］FBPA Commissioned by CICS and Sumitomo Heavy Industries and STELLA PHARMA

Phase 1/2 Enrolling by invitation

BreastGastrointestinalOther solid neoplasmSarcomaThoracic

Mesothelioma, Malignant, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Esophageal Neoplasms, Neurofibrosarcoma

NCT04954625 2025-10-10

Prolonged Air Leak (PAL) Autologous Blood Patch Intervention Trial

Phase NA Enrolling by invitation

Lung Neoplasms

NCT07214441 2025-10-09

Evaluating the Feasibility and Preliminary Effects of BE+

Phase NA Enrolling by invitation

Carcinoma, Non-Small-Cell Lung, Motor Activity

NCT07167459 2025-09-11

Personalized SBRT in Early-Stage Peripheral NSCLC

Phase 2 Enrolling by invitation

Early-stage Peripheral Non-small Cell Lung Cancer

NCT06228209 2025-09-04

TIER-PC

Phase NA Enrolling by invitation

GastrointestinalThoracic

Advanced Heart Failure

NCT07125573 2025-08-15

The Effect of Esketamine Combined With Dexmedetomidine on Postoperative Recovery Quality in Patients Undergoing Thoracoscopic Surgery

Phase NA Enrolling by invitation

Lung Neoplasms

NCT07023068 2025-06-15

⁶⁸Ga-DPA in the Lung Cancer Diagnosis

Phase EARLY_PHASE1 Enrolling by invitation

Lung Neoplasms

NCT05844761 2025-05-21

REMIND

Phase NA Enrolling by invitation

GenitourinaryThoracic

Lung Neoplasms, Prostatic Neoplasms

NCT06419179 2025-05-20

GUIDANCE

Phase 2 Enrolling by invitation

Small Cell Lung Carcinoma

NCT06690216 2025-03-30

PD-L1-PET

Phase 1/2 Enrolling by invitation

CNSGastrointestinalHead & NeckThoracic

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Non-Small-Cell Lung, Esophageal Neoplasms, Glioblastoma

NCT06848738 2025-02-27

IMPROVED

Phase NA Enrolling by invitation

LymphoidThoracic

Lung Neoplasms, Lymphoma, Sarcoidosis

NCT06816966 2025-02-10

CISART

Phase 2 Enrolling by invitation

Small Cell Lung Carcinoma

NCT06773156 2025-01-14

Adjuvant Adebrelimab Plus Apatinib After Chemoradiation in Limited-Stage Small Cell Lung Cancer

Phase 2 Enrolling by invitation

Small Cell Lung Carcinoma

NCT06759857 2025-01-06

FHND9041

Phase 3 Enrolling by invitation

Carcinoma, Non-Small-Cell Lung

NCT06752395 2025-01-03

Cryobiopsy Vs. Forceps Biopsy for Peripheral Pulmonary Lesions

Phase NA Enrolling by invitation

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT06747832 2024-12-24

iNK-SCLC

Phase EARLY_PHASE1 Enrolling by invitation

Small Cell Lung Carcinoma

NCT06028412 2024-10-15

Comparison of Sublobar and Lobectomy in Small (2 Cm or Less 0.5<CTR<1) Non-small Cell Lung Cancer: a Prospective, Multicenter Randomized Controlled Study

Phase NA Enrolling by invitation

Carcinoma, Non-Small-Cell Lung

NCT05863013 2024-05-16

Use of the ADL-Glittre Test in the Pre and Postoperative Period of Patients With Lung Cancer

Phase NA Enrolling by invitation

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT04762459 2022-02-24

APEX

Phase 3 Enrolling by invitation

Carcinoma, Non-Small-Cell Lung